Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar
Cholangiocarcinoma
Gastrointestinal cancers Notes: Diagrams & Illustrations | Osmosis
Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version - Siteman Cancer Center
![PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fc268883b0831b6fe2dfbf376ed5fd1d8aba128/6-Table1-1.png "PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar")
PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document | Gut
Predictive value of multiple serum tumor markers | CMAR
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
Cholangiocarcinoma
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
Establishment and Characterization of a Cholangiocarcinoma Cell Line from a Thai Patient with Intrahepatic Bile Duct Cancer
Cancers | Free Full-Text | Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma | HTML
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis - ScienceDirect
Tumour markers and cytological methods for diagnosis of cholangiocarcinoma | Download Table
Surface Markers of Cancer Stem Cells in Cholangiocarcinoma (CCA). | Download Scientific Diagram
Cholangiocarcinoma - YouTube
KoreaMed Synapse
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
Cholangiocarcinoma - The Lancet
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/942919bec9429e21c4d8ed2b634a865a13da7cad/3-Table2-1.png "PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar")